97 results
Page 3 of 5
8-K
ezn3p6ijt3txq zc
13 Mar 14
NW Bio Receives Recommendation To Continue With Phase III GBM Brain Cancer Trial Based On Data Safety Monitoring Board’s Safety Review
12:00am
424B5
ljs5c1
21 Nov 13
Prospectus supplement for primary offering
12:00am
424B5
xvqi99wvvv4vw3
19 Nov 13
Prospectus supplement for primary offering
12:00am
424B5
bdxk7t43m6zi9ks
9 Aug 13
Prospectus supplement for primary offering
12:00am
424B5
maogu9u
22 Apr 13
Prospectus supplement for primary offering
12:00am
8-K
v6fpego xnc
22 Apr 13
NW Bio Announces $10 Million Registered Direct Offering
12:00am
8-K
EX-99.1
l0dc2o15fp5e7
22 Apr 13
NW Bio Announces $10 Million Registered Direct Offering
12:00am
8-K
EX-99.1
olkkjv352s4950d
8 Apr 13
NW Bio 2012 ANNUAL REPORT SHOWS STRONG PROGRESS
12:00am
S-3/A
hazrbiq
25 Jan 13
Shelf registration (amended)
12:00am
S-3
jzy3pkzc ly
7 Jan 13
Shelf registration
12:00am
424B4
xprwee
10 Dec 12
Prospectus supplement with pricing info
12:00am
8-K
9pst yk6g4zwzlur
29 Aug 12
Northwest Bio Receives Regulatory Approval To Proceed With Its Phase III Trial In The UK
12:00am
8-K
EX-99.1
27v6m 3jsga
29 Aug 12
Northwest Bio Receives Regulatory Approval To Proceed With Its Phase III Trial In The UK
12:00am